Pricing Log in Create free account

Biodesix, Inc. (BDSX) vs Insight Molecular Diagnostics Inc. (IMDX)

Biodesix, Inc. and Insight Molecular Diagnostics Inc. are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $209.3M against $80.5M — 2.6× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 31.2% against −60.8%. Biodesix, Inc. has the higher net margin (−25.7% vs −2,955.6%) and the lower return on invested capital (−44.8% vs 0.00%). Across the 17 metrics below, Biodesix, Inc. leads on 11 and Insight Molecular Diagnostics Inc. on 6.

Valuation

Metric BDSX IMDX Diagnostics & Research median
P/E n/m n/m 34.52
P/S 2.01 53.47 4.24
P/B 24.38 n/m 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 2.19 42.95 5.18
Earnings yield (13.91%) (61.32%) (1.50%)
Free cash flow yield (9.11%) (34.71%) 0.00%

Profitability

Metric BDSX IMDX Diagnostics & Research median
Gross margin 0.00% 48.32% 48.32%
Operating margin (18.69%) (3,011.86%) (5.68%)
Net margin (25.74%) (2,955.63%) (4.10%)
Free cash flow margin (18.30%) (1,856.23%) 0.00%
Return on equity (778.89%) 488.68% 0.00%
Return on assets (29.65%) (123.46%) (6.05%)
Return on invested capital (44.84%) 0.00% 0.00%

Growth

Metric BDSX IMDX Diagnostics & Research median
Revenue growth (TTM) 31.23% (60.77%) 8.99%
EPS growth (last fiscal year) 29.24% 64.59% 20.36%
Revenue growth, 5-year CAGR 14.20% 27.24% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX IMDX Diagnostics & Research median
Debt to equity 5.43 (0.04) 0.01
Current ratio 2.96 2.00 2.27
Net debt to EBITDA (1.36) (0.67) 0.68

Dividend

Metric BDSX IMDX Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric BDSX IMDX Diagnostics & Research median
Market cap 209.33m 80.50m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack